Your cart is empty.
Männedorf, Switzerland, September 01, 2011 – Tecan today announces the commercial availability of the new HP D300 Digital Dispenser, a simple, standalone instrument for the pharmaceutical sector, which uses HP Direct Digital Dispensing technology to rapidly deliver picoliter to microliter volumes of drug compounds. Available exclusively through Tecan, this innovative device can cut titration times from hours or days to just minutes. Based on HP inkjet technology, the Digital Dispenser is the result of an agreement between Tecan and HP to commercialize this new technology
for use in drug discovery research.
The HP D300 provides fast and reliable performance across a large dynamic range, eliminating the need for slow, error-prone and wasteful serial dilutions. Using disposable dispenseheads to help avoid the possibility of cross-contamination, the instrument offers non-contact digital dispensing from 13 pl to 5 µl, delivering any dose to any well and virtually eliminating waste of valuable compounds. It combines walk up convenience, ready-to-run performance and flexible, intuitive experiment design software to increase research productivity, reliability of results and the speed of drug discovery workflows.
Wendy Lauber, Head Product Management for Liquid Handling and Consumables at Tecan, commented: “The pharmaceutical industry is recognizing a need for change, and there is a growing trend towards benchtop automation solutions. New technologies such as Direct Digital Titration can offer fresh solutions to entrenched challenges, helping to improve productivity and accelerate the discovery of better drugs.”
The HP D300 Digital Dispenser is available now for delivery in Europe and North America. To find out more about Direct Digital Titration, go to www.tecan.com/digitaltitration
For more information please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019).